CRO” operating faster, more reliable clinical trials for life science pioneers, and Quotient Sciences, a global clinical development and manufacturing accelerator, have formed a strategic partnership ...

Horiba, Japanese manufacturer of precision instruments, has recently released the Veloci BioPharma Analyser, a spectroscopy solution for pharma and biopharma industries. The A-TEEM spectroscopy ...

Creative Biolabs, providers of integrated solutions encompassing viral vector design, construction, production, purification, and quality control, is expanding its end-to-end viral vector design and ...

Scottish Brain Sciences (SBS), a leading clinical research organisation dedicated to transforming the early detection and treatment of Alzheimer’s disease and other neurodegenerative conditions, has ...

Technology company Expert Intelligence has introduced EI Onsite, an AI infrastructure for pharmaceutical and biotechnology laboratories at this year’s Society for Laboratory Automation and Screening ...

Thermo Fisher Scientific has enrolled the first patient in its new PPD CorEvitas Alzheimer’s Disease Registry. Developed as an international, multi-country initiative, the registry will generate ...

The Start Centre for Cancer Research (Start), its preclinical division XenoStart, and Minerva Imaging have expanded their decade-long partnership to establish a comprehensive integrated platform for ...

Indivumed has formed a partnership with the Wilmot Cancer Institute at the University of Rochester Medical Centre (URMC). Utilising Indivumed’s approach to standardised tissue and clinical data ...

Newcastle-based biotech startup, 3D Bio-Tissues (3DBT), has produced ‘tissue-engineered skin’ grown solely from cells for use in the luxury goods market. With tanning expertise provided by the ...

Beckman Coulter Life Sciences, a specialist in laboratory automation and innovation, has launched the Biomek i3 benchtop liquid handler. With intuitive software, a user-friendly interface, and no ...

Cell and gene therapy CDMO eXmoor Pharma has collaborated with University College London (UCL) to accelerate the development of novel cell and gene therapies from academic research into clinical ...

AstraZeneca and Daiichi Sankyo’s Enhertu has received Breakthrough Therapy Designation (BTD) in the US for adult patients with HER2-positive early breast cancer with residual invasive disease in the ...